Vahram Haroutunian

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Living Beings

Rats
Mice

Chemicals & Drugs

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Beeri Michal Schnaider; Schmeidler James; Haroutunian Vahram; West Rebecca; Ostad Doris; Grossman Hillel T; Rosendorff Clive; Silverman Jeremy M
Better cognitive performance associated with worse cardiac functioning suggests antagonistic pleiotropy in very elderly subjects.
Libow Leslie S; Frisina Pasquale G; Haroutunian Vahram; Perl Daniel P; Purohit Dushyant P
Parkinson's disease dementia: a diminished role for the Lewy body.
Beeri Michal Schnaider; Rapp Michael; Schmeidler James; Reichenberg Abraham; Purohit Dushyant P; Perl Daniel P; Grossman Hillel T; Prohovnik Isak; Haroutunian Vahram; Silverman Jeremy M
Number of children is associated with neuropathology of Alzheimer's disease in women.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vahram Haroutunian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Beeri Michal Schnaider; Schmeidler James; Haroutunian Vahram; West Rebecca; Ostad Doris; Grossman Hillel T; Rosendorff Clive; Silverman Jeremy M
Better cognitive performance associated with worse cardiac functioning suggests antagonistic pleiotropy in very elderly subjects.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2009;17(10):911-2.
2009: Libow Leslie S; Frisina Pasquale G; Haroutunian Vahram; Perl Daniel P; Purohit Dushyant P
Parkinson's disease dementia: a diminished role for the Lewy body.
Parkinsonism & related disorders 2009;15(8):572-5.
2009: Beeri Michal Schnaider; Rapp Michael; Schmeidler James; Reichenberg Abraham; Purohit Dushyant P; Perl Daniel P; Grossman Hillel T; Prohovnik Isak; Haroutunian Vahram; Silverman Jeremy M
Number of children is associated with neuropathology of Alzheimer's disease in women.
Neurobiology of aging 2009;30(8):1184-91.
2009: Bauer Deborah Elaine; Haroutunian Vahram; McCullumsmith Robert E; Meador-Woodruff James H
Expression of four housekeeping proteins in elderly patients with schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(4):487-91.
2009: Haroutunian Vahram; Katsel Pavel; Schmeidler James
Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.
Neurobiology of aging 2009;30(4):561-73.
2009: Qin Weiping; Haroutunian Vahram; Katsel Pavel; Cardozo Christopher P; Ho Lap; Buxbaum Joseph D; Pasinetti Giulio M
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
Archives of neurology 2009;66(3):352-61.
2009: Amadio Marialaura; Pascale Alessia; Wang Jun; Ho Lap; Quattrone Alessandro; Gandy Sam; Haroutunian Vahram; Racchi Marco; Pasinetti Giulio Maria
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
Journal of Alzheimer's disease : JAD 2009;16(2):409-19.
2009: Frisina Pasquale G; Haroutunian Vahram; Libow Leslie S
The neuropathological basis for depression in Parkinson's disease.
Parkinsonism & related disorders 2009;15(2):144-8.
2009: Katsel Pavel; Tan Weilun; Haroutunian Vahram
Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.
PloS one 2009;4(10):e7642.
2009: Beeri Michal Schnaider; Ravona-Springer Ramit; Silverman Jeremy M; Haroutunian Vahram
The effects of cardiovascular risk factors on cognitive compromise.
Dialogues in clinical neuroscience 2009;11(2):201-12.
2009: Haroutunian Vahram; Hoffman Lisa B; Beeri Michal Schnaider
Is there a neuropathology difference between mild cognitive impairment and dementia?
Dialogues in clinical neuroscience 2009;11(2):171-9.
2009: Kajiwara Yuji; Akram Afia; Katsel Pavel; Haroutunian Vahram; Schmeidler James; Beecham Gary; Haines Jonathan L; Pericak-Vance Margaret A; Buxbaum Joseph D
FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4.
PloS one 2009;4(4):e5071.
2009: Lesser Gerson T; Haroutunian Vahram; Purohit Dushyant P; Schnaider Beeri Michal; Schmeidler James; Honkanen Linda; Neufeld Richard; Libow Leslie S
Serum lipids are related to Alzheimer's pathology in nursing home residents.
Dementia and geriatric cognitive disorders 2009;27(1):42-9.
2008: Rao Mala V; Mohan Panaiyur S; Peterhoff Corrinne M; Yang Dun-Sheng; Schmidt Stephen D; Stavrides Philip H; Campbell Jabbar; Chen Yuanxin; Jiang Ying; Paskevich Peter A; Cataldo Anne M; Haroutunian Vahram; Nixon Ralph A
Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(47):12241-54.
2008: Katsel Pavel; Davis Kenneth L; Li Celeste; Tan Weilun; Greenstein Elizabeth; Kleiner Hoffman Lisa B; Haroutunian Vahram
Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2993-3009.
2008: Dracheva S; Patel N; Woo D A; Marcus S M; Siever L J; Haroutunian V
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
Molecular psychiatry 2008;13(11):1001-10.
2008: Haroutunian Vahram; Schnaider-Beeri Michal; Schmeidler James; Wysocki Michael; Purohit Dushyant P; Perl Daniel P; Libow Leslie S; Lesser Gerson T; Maroukian Maria; Grossman Hillel T
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.
Archives of neurology 2008;65(9):1211-7.
2008: Beeri M S; Schmeidler J; Silverman J M; Gandy S; Wysocki M; Hannigan C M; Purohit D P; Lesser G; Grossman H T; Haroutunian V
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology.
Neurology 2008;71(10):750-7.
2008: Akram Afia; Christoffel Daniel; Rocher Anne B; Bouras Constantin; Kövari Enikö; Perl Daniel P; Morrison John H; Herrmann François R; Haroutunian Vahram; Giannakopoulos Panteleimon; Hof Patrick R
Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease.
Neurobiology of aging 2008;29(9):1296-307.
2008: Steffek Amy E; McCullumsmith Robert E; Haroutunian Vahram; Meador-Woodruff James H
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.
Schizophrenia research 2008;103(1-3):71-82.
2008: Elder Gregory A; Ragnauth Andre; Dorr Nathan; Franciosi Sonia; Schmeidler James; Haroutunian Vahram; Buxbaum Joseph D
Increased locomotor activity in mice lacking the low-density lipoprotein receptor.
Behavioural brain research 2008;191(2):256-65.
2008: Dracheva Stella; Byne William; Chin Benjamin; Haroutunian Vahram
Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia.
Brain research 2008;1214():23-34.
2008: Baker David A; Madayag Aric; Kristiansen Lars V; Meador-Woodruff James H; Haroutunian Vahram; Raju Ilangovan
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1760-72.
2008: Oni-Orisan Akin; Kristiansen Lars V; Haroutunian Vahram; Meador-Woodruff James H; McCullumsmith Robert E
Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.
Biological psychiatry 2008;63(8):766-75.
2008: Lauriat Tara L; Shiue Lily; Haroutunian Vahram; Verbitsky Miguel; Ares Manuel; Ospina Luz; McInnes L Alison
Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity.
Journal of neuroscience research 2008;86(4):785-96.
2008: Dracheva Stella; Chin Benjamin; Haroutunian Vahram
Altered serotonin 2C receptor RNA splicing in suicide: association with editing.
Neuroreport 2008;19(3):379-82.
2008: Rapp Michael A; Schnaider-Beeri Michal; Purohit Dushyant P; Perl Daniel P; Haroutunian Vahram; Sano Mary
Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(2):168-74.
2008: Byne William; Dracheva Stella; Chin Benjamin; Schmeidler James M; Davis Kenneth L; Haroutunian Vahram
Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.
Schizophrenia research 2008;98(1-3):118-28.
2008: Alelú-Paz Raúl; Iturrieta-Zuazo Ignacio; Byne William; Haroutunian Vahram; García-Villanueva Mercedes; Rábano Alberto; García-Amado María; Prensa Lucía; Giménez-Amaya José Manuel
A new antigen retrieval technique for human brain tissue.
PloS one 2008;3(10):e3378.
2008: Schnaider Beeri Michal; Silverman Jeremy M; Schmeidler James; Wysocki Michael; Grossman Hillel Z; Purohit Dushyant P; Perl Daniel P; Haroutunian Vahram
Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology.
Dementia and geriatric cognitive disorders 2008;25(5):392-8.
2007: Yakovleva T; Marinova Z; Kuzmin A; Seidah N G; Haroutunian V; Terenius L; Bakalkin G
Dysregulation of dynorphins in Alzheimer disease.
Neurobiology of aging 2007;28(11):1700-8.
2007: Haroutunian Vahram; Pickett Jane
Autism brain tissue banking.
Brain pathology (Zurich, Switzerland) 2007;17(4):412-21.
2007: Haroutunian Vahram; Davis Kenneth L
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):499-502.
2007: Elder Gregory A; Cho Julie Y; English Daniel F; Franciosi Sonia; Schmeidler James; Sosa Miguel A Gama; Gasperi Rita De; Fisher Edward A; Mathews Paul M; Haroutunian Vahram; Buxbaum Joseph D
Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor.
Journal of neurochemistry 2007;102(4):1220-31.
2007: Haroutunian Vahram; Katsel Pavel; Dracheva Stella; Stewart Daniel G; Davis Kenneth L
Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):565-73.
2007: Gill Sandeep K; Ishak Margaret; Dobransky Tomas; Haroutunian Vahram; Davis Kenneth L; Rylett R Jane
82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease.
Neurobiology of aging 2007;28(7):1028-40.
2007: Zhao Zhong; Xiang Zhongmin; Haroutunian Vahram; Buxbaum Joseph D; Stetka Breton; Pasinetti Giulio Maria
Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.
Neurobiology of aging 2007;28(6):824-30.
2007: Katsel Pavel; Li Celeste; Haroutunian Vahram
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Neurochemical research 2007;32(4-5):845-56.
2007: McCullumsmith Robert E; Gupta Daya; Beneyto Monica; Kreger Emily; Haroutunian Vahram; Davis Kenneth L; Meador-Woodruff James H
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.
Schizophrenia research 2007;90(1-3):15-27.
2007: Byne William; Fernandes Jason; Haroutunian Vhram; Huacon Dennis; Kidkardnee Smith; Kim John; Tatusov Alex; Thakur Uma; Yiannoulos Georgia
Reduction of right medial pulvinar volume and neuron number in schizophrenia.
Schizophrenia research 2007;90(1-3):71-5.
2007: Haroutunian V; Davies P; Vianna C; Buxbaum J D; Purohit D P
Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
Neurobiology of aging 2007;28(1):1-7.
2007: Greenstein Robert J; Su Liya; Haroutunian Vahram; Shahidi Azra; Brown Sheldon T
On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis.
PloS one 2007;2(1):e161.
2006: Lauriat Tara L; Dracheva Stella; Kremerskothen Joachim; Duning Kerstin; Haroutunian Vahram; Buxbaum Joseph D; Hyde Thomas M; Kleinman Joel E; McInnes L Alison
Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton.
Brain research 2006;1121(1):1-11.
2006: Haroutunian Vahram; Katsel Pavel; Dracheva Stella; Davis Kenneth L
The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia.
The American journal of psychiatry 2006;163(10):1834-7.
2006: Baracskay Karen L; Haroutunian Vahram; Meador-Woodruff James H
Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
Synapse (New York, N.Y.) 2006;60(4):271-9.
2006: Georgieva Lyudmila; Moskvina Valentina; Peirce Tim; Norton Nadine; Bray Nicholas J; Jones Lesley; Holmans Peter; Macgregor Stuart; Zammit Stanley; Wilkinson Jennifer; Williams Hywel; Nikolov Ivan; Williams Nigel; Ivanov Dobril; Davis Kenneth L; Haroutunian Vahram; Buxbaum Joseph D; Craddock Nick; Kirov George; Owen Michael J; O'Donovan Michael C
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(33):12469-74.
2006: Clinton Sarah M; Haroutunian Vahram; Meador-Woodruff James H
Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
Journal of neurochemistry 2006;98(4):1114-25.
2006: Kristiansen L V; Beneyto M; Haroutunian V; Meador-Woodruff J H
Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Molecular psychiatry 2006;11(8):737-47, 705.
2006: Steffek Amy E; Haroutunian Vahram; Meador-Woodruff James H
Serine racemase protein expression in cortex and hippocampus in schizophrenia.
Neuroreport 2006;17(11):1181-5.
2006: Religa D; Strozyk D; Cherny R A; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush A I
Elevated cortical zinc in Alzheimer disease.
Neurology 2006;67(1):69-75.
2006: Byne William; Kidkardnee Smith; Tatusov Alex; Yiannoulos Georgia; Buchsbaum Monte S; Haroutunian Vahram
Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus.
Schizophrenia research 2006;85(1-3):245-53.
2006: Huerta Ibone; McCullumsmith Robert E; Haroutunian Vahram; Giménez-Amaya José Manuel; Meador-Woodruff James H
Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Synapse (New York, N.Y.) 2006;59(7):394-402.
2006: Beeri M S; Rapp M; Silverman J M; Schmeidler J; Grossman H T; Fallon J T; Purohit D P; Perl D P; Siddiqui A; Lesser G; Rosendorff C; Haroutunian V
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.
Neurology 2006;66(9):1399-404.
2006: Zhao Zhong; Ksiezak-Reding Hanna; Riggio Silvana; Haroutunian Vahram; Pasinetti Giulio M
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
Schizophrenia research 2006;84(1):1-14.
2006: Dracheva Stella; Davis Kenneth L; Chin Benjamin; Woo Derek A; Schmeidler James; Haroutunian Vahram
Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.
Neurobiology of disease 2006;21(3):531-40.
2006: Rapp Michael A; Schnaider-Beeri Michal; Grossman Hillel T; Sano Mary; Perl Daniel P; Purohit Dushyant P; Gorman Jack M; Haroutunian Vahram
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
Archives of general psychiatry 2006;63(2):161-7.
2006: Lauriat T L; Dracheva S; Chin B; Schmeidler J; McInnes L A; Haroutunian V
Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.
Neuroscience 2006;137(3):843-51.
2006: Prohovnik I; Perl D P; Davis K L; Libow L; Lesser G; Haroutunian V
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
Neurology 2006;66(1):49-55.
2006: Peirce Timothy R; Bray Nicholas J; Williams Nigel M; Norton Nadine; Moskvina Valentina; Preece Anna; Haroutunian Vahram; Buxbaum Joseph D; Owen Michael J; O'Donovan Michael C
Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia.
Archives of general psychiatry 2006;63(1):18-24.
2006: Xiang Zhongmin; Haroutunian Vahram; Ho Lap; Purohit Dushant; Pasinetti Giulio Maria
Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
Disease markers 2006;22(1-2):95-102.
2005: Zhao Zhong; Ho Lap; Wang Jun; Qin Weiping; Festa Eugene D; Mobbs Charles; Hof Patrick; Rocher Anne; Masur Sandra; Haroutunian Vahram; Pasinetti Giulio Maria
Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(14):2081-2.
2005: Katsel Pavel; Davis Kenneth L; Haroutunian Vahram
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.
Schizophrenia research 2005;79(2-3):157-73.
2005: Clinton Sarah M; Ibrahim Hisham M; Frey Kirk A; Davis Kenneth L; Haroutunian Vahram; Meador-Woodruff James H
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
The American journal of psychiatry 2005;162(10):1859-71.
2005: Gupta Daya S; McCullumsmith Robert E; Beneyto Monica; Haroutunian Vahram; Davis Kenneth L; Meador-Woodruff James H
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
Synapse (New York, N.Y.) 2005;57(3):123-31.
2005: Katsel P; Davis K L; Gorman J M; Haroutunian V
Variations in differential gene expression patterns across multiple brain regions in schizophrenia.
Schizophrenia research 2005;77(2-3):241-52.
2005: Rapp Michael A; Schnaider Beeri Michal; Schmeidler James; Sano Mary; Silverman Jeremy M; Haroutunian Vahram
Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adults.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(6):450-9.
2005: Bruneau Emile G; McCullumsmith Robert E; Haroutunian Vahram; Davis Kenneth L; Meador-Woodruff James H
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.
Schizophrenia research 2005;75(1):27-34.
2005: Bubber Parvesh; Haroutunian Vahram; Fisch Gene; Blass John P; Gibson Gary E
Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.
Annals of neurology 2005;57(5):695-703.
2005: Rapp Michael A; Schnaider-Beeri Michael; Sano Mary; Silverman Jeremy M; Haroutunian Vahram
Cross-domain variability of cognitive performance in very old nursing home residents and community dwellers: relationship to functional status.
Gerontology 2005;51(3):206-12.
2005: Beeri Michal Schnaider; Silverman Jeremy M; Davis Kenneth L; Marin Deborah; Grossman Hillel Z; Schmeidler James; Purohit Dushyant P; Perl Daniel P; Davidson Michael; Mohs Richard C; Haroutunian Vahram
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(4):471-5.
2005: Rapp Michael A; Dahlman Karen; Sano Mary; Grossman Hillel T; Haroutunian Vahram; Gorman Jack M
Neuropsychological differences between late-onset and recurrent geriatric major depression.
The American journal of psychiatry 2005;162(4):691-8.
2005: Dracheva Stella; McGurk Susan R; Haroutunian Vahram
mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Journal of neuroscience research 2005;79(6):868-78.
2005: Katsel Pavel L; Davis Kenneth L; Haroutunian Vahram
Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
International review of neurobiology 2005;63():41-82.
2004: Buckland Paul R; Hoogendoorn Bastiaan; Guy Carol A; Coleman Sharon L; Smith S Kaye; Buxbaum Joseph D; Haroutunian Vahram; O'Donovan Michael C
A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity.
Biochimica et biophysica acta 2004;1690(3):238-49.
2004: Cataldo Anne M; Petanceska Suzana; Terio Nicole B; Peterhoff Corrinne M; Durham Robert; Mercken Marc; Mehta Pankaj D; Buxbaum Joseph; Haroutunian Vahram; Nixon Ralph A
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Neurobiology of aging 2004;25(10):1263-72.
2004: Brown Abraham M; Gordon Derek; Lee Hsinhwa; Caudy Michael; Hardy John; Haroutunian Vahram; Blass John P
Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;131B(1):60-6.
2004: Bray Nicholas J; Jehu Luke; Moskvina Valentina; Buxbaum Joseph D; Dracheva Stella; Haroutunian Vahram; Williams Julie; Buckland Paul R; Owen Michael J; O'Donovan Michael C
Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Human molecular genetics 2004;13(22):2885-92.
2004: Bai Jie; He Fang; Novikova Svetlana I; Undie Ashiwel S; Dracheva Stella; Haroutunian Vahram; Lidow Michael S
Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.
Biological psychiatry 2004;56(6):427-40.
2004: Wen Paul H; Hof Patrick R; Chen Xiaoping; Gluck Karen; Austin Gregory; Younkin Steven G; Younkin Linda H; DeGasperi Rita; Gama Sosa Miguel A; Robakis Nikolaos K; Haroutunian Vahram; Elder Gregory A
The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Experimental neurology 2004;188(2):224-37.
2004: Dracheva Stella; Elhakem Sharif L; McGurk Susan R; Davis Kenneth L; Haroutunian Vahram
GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
Journal of neuroscience research 2004;76(4):581-92.
2004: Brown Abraham M; Gordon Derek; Lee Hsinhwa; Caudy Michael; Haroutunian Vahram; Blass John P
Substantial linkage disequilibrium across the dihydrolipoyl succinyltransferase gene region without Alzheimer's disease association.
Neurochemical research 2004;29(3):629-35.
2004: Mueller Helena T; Haroutunian Vahram; Davis Kenneth L; Meador-Woodruff James H
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
Brain research. Molecular brain research 2004;121(1-2):60-9.
2004: Santucci Anthony C; Haroutunian Vahram
p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesions.
Pharmacology, biochemistry, and behavior 2004;77(1):59-67.
2004: Gordon Derek; Yang Yaning; Haynes Chad; Finch Stephen J; Mendell Nancy R; Brown Abraham M; Haroutunian Vahram
Increasing power for tests of genetic association in the presence of phenotype and/or genotype error by use of double-sampling.
Statistical applications in genetics and molecular biology 2004;3():Article26.
2004: Bubber Parvesh; Tang Jicheng; Haroutunian Vahram; Xu Hui; Davis Kenneth L; Blass John P; Gibson Gary E
Mitochondrial enzymes in schizophrenia.
Journal of molecular neuroscience : MN 2004;24(2):315-21.
2003: Dracheva Stella; Elhakem Sharif L; Marcus Sue M; Siever Larry J; McGurk Susan R; Haroutunian Vahram
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia.
Journal of neurochemistry 2003;87(6):1402-12.
2003: Halks-Miller Meredith; Schroeder Miriam L; Haroutunian Vahram; Moenning Ursula; Rossi Michael; Achim Cristian; Purohit Dushyant; Mahmoudi Mithra; Horuk Richard
CCR1 is an early and specific marker of Alzheimer's disease.
Annals of neurology 2003;54(5):638-46.
2003: Causevic Mirsada; Ramoz Nicolas; Haroutunian Vahram; Davis Kenneth L; Buxbaum Joseph D
Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype.
Journal of neuropathology and experimental neurology 2003;62(10):999-1005.
2003: Lilliehook Christina; Bozdagi Ozlem; Yao Jun; Gomez-Ramirez Manuel; Zaidi Nikhat F; Wasco Wilma; Gandy Sam; Santucci Anthony C; Haroutunian Vahram; Huntley George W; Buxbaum Joseph D
Altered Abeta formation and long-term potentiation in a calsenilin knock-out.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(27):9097-106.
2003: Polesskaya Oxana O; Haroutunian Vahram; Davis Kenneth L; Hernandez Ivan; Sokolov Boris P
Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia.
Journal of neuroscience research 2003;74(1):111-22.
2003: Davis Kenneth L; Haroutunian Vahram
Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Lancet 2003;362(9386):758.
2003: Hof Patrick R; Haroutunian Vahram; Friedrich Victor L; Byne William; Buitron Cristian; Perl Daniel P; Davis Kenneth L
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.
Biological psychiatry 2003;53(12):1075-85.
2003: Clinton Sarah M; Haroutunian Vahram; Davis Kenneth L; Meador-Woodruff James H
Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2003;160(6):1100-9.
2003: Davis Kenneth L; Stewart Daniel G; Friedman Joseph I; Buchsbaum Monte; Harvey Philip D; Hof Patrick R; Buxbaum Joseph; Haroutunian Vahram
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Archives of general psychiatry 2003;60(5):443-56.
2003: Religa Dorota; Laudon Hanna; Styczynska Maria; Winblad Bengt; Näslund Jan; Haroutunian Vahram
Amyloid beta pathology in Alzheimer's disease and schizophrenia.
The American journal of psychiatry 2003;160(5):867-72.
2003: Serby Michael; Brickman Adam M; Haroutunian Vahram; Purohit Dushyant P; Marin Deborah; Lantz Melinda; Mohs Richard C; Davis Kenneth L
Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(3):371-4.
2003: Pompl Patrick N; Yemul Shrishailam; Xiang Zhongmin; Ho Lap; Haroutunian Varham; Purohit Dushyant; Mohs Richard; Pasinetti Giulio Maria
Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.
Archives of neurology 2003;60(3):369-76.
2002: Hof Patrick R; Haroutunian Vahram; Copland Christina; Davis Kenneth L; Buxbaum Joseph D
Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.
Neurochemical research 2002;27(10):1193-200.
2002: Utsuki Tadanobu; Shoaib Mohammed; Holloway Harold W; Ingram Donald K; Wallace William C; Haroutunian Vahram; Sambamurti Kumar; Lahiri Debomoy K; Greig Nigel H
Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.
Journal of Alzheimer's disease : JAD 2002;4(5):405-15.
2002: Haroutunian Vahram; Davis Kenneth L
Issues and perspectives on brain tissue banking.
Current psychiatry reports 2002;4(4):233-4.
2002: Gluck Martin R; Thomas Rohan G; Davis Kenneth L; Haroutunian Vahram
Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
The American journal of psychiatry 2002;159(7):1165-73.
2002: Byne William; Buchsbaum Monte S; Mattiace Linda A; Hazlett Erin A; Kemether Eileen; Elhakem Sharif L; Purohit Dushyant P; Haroutunian Vahram; Jones Liesl
Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia.
The American journal of psychiatry 2002;159(1):59-65.
2001: Parvathy S; Davies P; Haroutunian V; Purohit D P; Davis K L; Mohs R C; Park H; Moran T M; Chan J Y; Buxbaum J D
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
Archives of neurology 2001;58(12):2025-32.
2001: Smith R E; Haroutunian V; Davis K L; Meador-Woodruff J H
Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
Neuroreport 2001;12(13):2885-7.
2001: Dracheva S; Marras S A; Elhakem S L; Kramer F R; Davis K L; Haroutunian V
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
The American journal of psychiatry 2001;158(9):1400-10.
2001: Smith R E; Haroutunian V; Davis K L; Meador-Woodruff J H
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2001;158(9):1393-9.
2001: Dracheva S; Haroutunian V
Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice.
Brain research 2001;905(1-2):142-51.
2001: Meador-Woodruff J H; Davis K L; Haroutunian V
Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):545-52.
2001: Hakak Y; Walker J R; Li C; Wong W H; Davis K L; Buxbaum J D; Haroutunian V; Fienberg A A
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(8):4746-51.
2001: Ho L; Purohit D; Haroutunian V; Luterman J D; Willis F; Naslund J; Buxbaum J D; Mohs R C; Aisen P S; Pasinetti G M
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.
Archives of neurology 2001;58(3):487-92.
2001: Lesser G; Kandiah K; Libow L S; Likourezos A; Breuer B; Marin D; Mohs R; Haroutunian V; Neufeld R
Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2001;12(2):138-45.
2001: Brown A M; Sheu R K; Mohs R; Haroutunian V; Blass J P
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA).
Journal of molecular neuroscience : MN 2001;16(1):41-8.
2001: Ho L; Guo Y; Spielman L; Petrescu O; Haroutunian V; Purohit D; Czernik A; Yemul S; Aisen P S; Mohs R; Pasinetti G M
Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.
Neuroscience letters 2001;298(3):191-4.
2000: Ibrahim H M; Hogg A J; Healy D J; Haroutunian V; Davis K L; Meador-Woodruff J H
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
The American journal of psychiatry 2000;157(11):1811-23.
2000: Gibson G E; Haroutunian V; Zhang H; Park L C; Shi Q; Lesser M; Mohs R C; Sheu R K; Blass J P
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
Annals of neurology 2000;48(3):297-303.
2000: Luterman J D; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen P S; Mohs R; Pasinetti G M
Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
Archives of neurology 2000;57(8):1153-60.
2000: Haroutunian V; Serby M; Purohit D P; Perl D P; Marin D; Lantz M; Mohs R C; Davis K L
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.
Archives of neurology 2000;57(8):1145-50.
2000: Sokolov B P; Tcherepanov A A; Haroutunian V; Davis K L
Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.
Biological psychiatry 2000;48(3):184-96.
2000: Harvey P D; Jacobsen H; Mancini D; Parrella M; White L; Haroutunian V; Davis K L
Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients.
Schizophrenia research 2000;43(1):3-9.
2000: Perry E; Martin-Ruiz C; Lee M; Griffiths M; Johnson M; Piggott M; Haroutunian V; Buxbaum J D; Nãsland J; Davis K; Gotti C; Clementi F; Tzartos S; Cohen O; Soreq H; Jaros E; Perry R; Ballard C; McKeith I; Court J
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
2000: Näslund J; Haroutunian V; Mohs R; Davis K L; Davies P; Greengard P; Buxbaum J D
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
JAMA : the journal of the American Medical Association 2000;283(12):1571-7.
2000: Gluck M R; Jayatilleke E; Shaw S; Rowan A J; Haroutunian V
CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy.
Epilepsy research 2000;39(1):63-71.
2000: Richardson-Burns S M; Haroutunian V; Davis K L; Watson S J; Meador-Woodruff J H
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus.
Biological psychiatry 2000;47(1):22-8.
2000: Gouras G K; Tsai J; Naslund J; Vincent B; Edgar M; Checler F; Greenfield J P; Haroutunian V; Buxbaum J D; Xu H; Greengard P; Relkin N R
Intraneuronal Abeta42 accumulation in human brain.
The American journal of pathology 2000;156(1):15-20.
1999: Davis K L; Mohs R C; Marin D B; Purohit D P; Perl D P; Lantz M; Austin G; Haroutunian V
Neuropeptide abnormalities in patients with early Alzheimer disease.
Archives of general psychiatry 1999;56(11):981-7.
1999: Haroutunian V; Purohit D P; Perl D P; Marin D; Khan K; Lantz M; Davis K L; Mohs R C
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
Archives of neurology 1999;56(6):713-8.
1999: Dracheva S; Xu M; Kelley K A; Haroutunian V; Holstein G R; Haun S; Silverstein J H; Sealfon S C
Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice.
Experimental neurology 1999;157(1):169-79.
1999: Davis K L; Mohs R C; Marin D; Purohit D P; Perl D P; Lantz M; Austin G; Haroutunian V
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
JAMA : the journal of the American Medical Association 1999;281(15):1401-6.
1999: Kaplan B; Haroutunian V; Koudinov A; Patael Y; Pras M; Gallo G
Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias.
Clinica chimica acta; international journal of clinical chemistry 1999;280(1-2):147-59.
1999: Sheu K F; Brown A M; Haroutunian V; Kristal B S; Thaler H; Lesser M; Kalaria R N; Relkin N R; Mohs R C; Lilius L; Lannfelt L; Blass J P
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.
Annals of neurology 1999;45(1):48-53.
1998: Healy D J; Haroutunian V; Powchik P; Davidson M; Davis K L; Watson S J; Meador-Woodruff J H
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(4):278-86.
1998: Shimon H; Sobolev Y; Davidson M; Haroutunian V; Belmaker R H; Agam G
Inositol levels are decreased in postmortem brain of schizophrenic patients.
Biological psychiatry 1998;44(6):428-32.
1998: Haroutunian V; Perl D P; Purohit D P; Marin D; Khan K; Lantz M; Davis K L; Mohs R C
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
Archives of neurology 1998;55(9):1185-91.
1998: Purohit D P; Perl D P; Haroutunian V; Powchik P; Davidson M; Davis K L
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Archives of general psychiatry 1998;55(3):205-11.
1998: Reznik-Wolf H; Machado J; Haroutunian V; DeMarco L; Walter G F; Goldman B; Davidson M; Johnston J A; Lannfelt L; Dani S U; Friedman E
Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains.
Journal of neurogenetics 1998;12(1):55-65.
1998: Powchik P; Davidson M; Haroutunian V; Gabriel S M; Purohit D P; Perl D P; Harvey P D; Davis K L
Postmortem studies in schizophrenia.
Schizophrenia bulletin 1998;24(3):325-41.
1997: Meador-Woodruff J H; Haroutunian V; Powchik P; Davidson M; Davis K L; Watson S J
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
Archives of general psychiatry 1997;54(12):1089-95.
1997: Powchik P; Friedman J; Haroutunian V; Greenberg D; Altsteil L; Purohit D; Perl D; Davidson M
Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination.
Biological psychiatry 1997;42(4):296-8.
1997: Gabriel S M; Haroutunian V; Powchik P; Honer W G; Davidson M; Davies P; Davis K L
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Archives of general psychiatry 1997;54(6):559-66.
1997: Haroutunian V; Greig N; Pei X F; Utsuki T; Gluck R; Acevedo L D; Davis K L; Wallace W C
Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.
Brain research. Molecular brain research 1997;46(1-2):161-8.
1997: Li G; Aryan M; Silverman J M; Haroutunian V; Perl D P; Birstein S; Lantz M; Marin D B; Mohs R C; Davis K L
The validity of the family history method for identifying Alzheimer disease.
Archives of neurology 1997;54(5):634-40.
1996: Haroutunian V; Zhou Y; Elder G; Li C; Lazzarini R A
Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene: I.
Brain research. Molecular brain research 1996;42(1):62-70.
1996: Meador-Woodruff J H; Damask S P; Wang J; Haroutunian V; Davis K L; Watson S J
Dopamine receptor mRNA expression in human striatum and neocortex.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(1):17-29.
1996: Santucci A C; Knott P J; Haroutunian V
Excessive serotonin release, not depletion, leads to memory impairments in rats.
European journal of pharmacology 1996;295(1):7-17.
1996: Gabriel S M; Davidson M; Haroutunian V; Powchik P; Bierer L M; Purohit D P; Perl D P; Davis K L
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
Biological psychiatry 1996;39(2):82-91.
1996: Klein J T; Davis L; Olsen G E; Wong G S; Huger F P; Smith C P; Petko W W; Cornfeldt M; Wilker J C; Blitzer R D; Landau E; Haroutunian V; Martin L L; Effland R C
Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.
Journal of medicinal chemistry 1996;39(2):570-81.
1996: Li G; Silverman J M; Altstiel L D; Haroutunian V; Perl D P; Purohit D; Birstein S; Lantz M; Mohs R C; Davis K L
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Genetic epidemiology 1996;13(3):285-98.
1995: Gabriel S M; Knott P J; Haroutunian V
Alterations in cerebral cortical galanin concentrations following neurotransmitter-specific subcortical lesions in the rat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(8):5526-34.
1995: Wallace W C; Lieberburg I; Schenk D; Vigo-Pelfrey C; Davis K L; Haroutunian V
Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(7 Pt 1):4896-905.
1995: Santucci A C; Kanof P D; Haroutunian V
Transient enhancement of cholinergic neurochemical markers induced by NGF in aged F344 rats.
Dementia (Basel, Switzerland) 1995;6(4):179-84.
1995: Lawlor B A; Ryan T M; Bierer L M; Schmeidler J; Haroutunian V; Mohs R; Davis K L
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
Biological psychiatry 1995;37(12):895-6.
1995: Bierer L M; Haroutunian V; Gabriel S; Knott P J; Carlin L S; Purohit D P; Perl D P; Schmeidler J; Kanof P; Davis K L
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
Journal of neurochemistry 1995;64(2):749-60.
1995: Miller M; Haroutunian V; Wiltshire-Clement M
Altered alertness of vasopressin-secreting transgenic mice.
Peptides 1995;16(8):1329-33.
1994: Haroutunian V; Davidson M; Kanof P D; Perl D P; Powchik P; Losonczy M; McCrystal J; Purohit D P; Bierer L M; Davis K L
Cortical cholinergic markers in schizophrenia.
Schizophrenia research 1994;12(2):137-44.
1994: Perry E K; Haroutunian V; Davis K L; Levy R; Lantos P; Eagger S; Honavar M; Dean A; Griffiths M; McKeith I G
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
Neuroreport 1994;5(7):747-9.
1994: Wallace W; Brane D; Hsu N; Khowong N; Merril C R; Haroutunian V
Characterization of gene expression in the cerebral cortices of rat brains containing subcortical lesions.
Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society 1994;4(1):33-8.
1993: Bierer L M; Knott P J; Schmeidler J M; Marin D B; Ryan T M; Haroutunian V; Purohit D P; Perl D P; Mohs R C; Davis K L
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms.
Psychiatry research 1993;49(3):211-7.
1993: Powchik P; Davidson M; Nemeroff C B; Haroutunian V; Purohit D; Losonczy M; Bissette G; Perl D; Ghanbari H; Miller B
Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment.
The American journal of psychiatry 1993;150(11):1726-7.
1993: Wallace W; Haroutunian V
Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein.
Behavioural brain research 1993;57(2):199-206.
1993: Schmauss C; Haroutunian V; Davis K L; Davidson M
Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8942-6.
1993: Wallace W; Ahlers S T; Gotlib J; Bragin V; Sugar J; Gluck R; Shea P A; Davis K L; Haroutunian V
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8712-6.
1993: Santucci A C; Gluck R; Kanof P D; Haroutunian V
Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM.
Dementia (Basel, Switzerland) 1993;4(5):273-81.
1993: Santucci A C; Kanof P D; Haroutunian V
Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats.
Brain research 1993;609(1-2):327-32.
1993: Purohit D P; Davidson M; Perl D P; Powchik P; Haroutunian V H; Bierer L M; McCrystal J; Losonczy M; Davis K L
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
Biological psychiatry 1993;33(4):255-60.
1992: Johnson G; Gotlib J; Haroutunian V; Bierer L; Nairn A C; Merril C; Wallace W
Increased phosphorylation of elongation factor 2 in Alzheimer's disease.
Brain research. Molecular brain research 1992;15(3-4):319-26.
1991: Perez N; Sugar J; Charya S; Johnson G; Merril C; Bierer L; Perl D; Haroutunian V; Wallace W
Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.
Brain research. Molecular brain research 1991;11(3-4):249-54.
1991: Wallace W C; Bragin V; Robakis N K; Sambamurti K; VanderPutten D; Merril C R; Davis K L; Santucci A C; Haroutunian V
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.
Brain research. Molecular brain research 1991;10(2):173-8.
1991: Parks K M; Sugar J E; Haroutunian V; Bierer L; Perl D; Wallace W C
Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues.
Brain research. Molecular brain research 1991;9(1-2):125-34.
1991: Santucci A C; Haroutunian V; Davis K L
Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.
Clinical neuropharmacology 1991;14 Suppl 1():S1-8.
1991: Santucci A C; Kanof P D; Haroutunian V
Fetal transplant-induced restoration of spatial memory in rats with lesions of the nucleus basalis of Meynert.
Journal of neural transplantation & plasticity 1991;2(1):65-74.
1990: Haroutunian V; Mantin R; Kanof P D
Frontal cortex as the site of action of physostigmine in nbM-lesioned rats.
Physiology & behavior 1990;47(1):203-6.
1990: Haroutunian V; Kanof P D; Tsuboyama G; Davis K L
Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.
Brain research 1990;507(2):261-6.
1990: Bierer L M; Perl D P; Haroutunian V; Mohs R C; Davis K L
Neurofibrillary tangles, Alzheimer's disease and Lewy bodies.
Lancet 1990;335(8682):163.
1990: Haroutunian V; Santucci A C; Davis K L
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.
Progress in brain research 1990;84():333-46.
1989: Anderson J P; Refolo L M; Wallace W; Mehta P; Krishnamurthi M; Gotlib J; Bierer L; Haroutunian V; Perl D; Robakis N K
Differential brain expression of the Alzheimer's amyloid precursor protein.
The EMBO journal 1989;8(12):3627-32.
1989: Haroutunian V; Kanof P D; Davis K L
Interactions of forebrain cholinergic and somatostatinergic systems in the rat.
Brain research 1989;496(1-2):98-104.
1989: Shutske G M; Pierrat F A; Kapples K J; Cornfeldt M L; Szewczak M R; Huger F P; Bores G M; Haroutunian V; Davis K L
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
Journal of medicinal chemistry 1989;32(8):1805-13.
1989: Santucci A C; Kanof P D; Haroutunian V
Infusion of NMDA into the nucleus basalis of Meynert, frontal cortex or lateral ventricle in rats: effect on memory and cholinergic brain neurochemistry.
Pharmacology, biochemistry, and behavior 1989;33(2):485-8.
1989: Santucci A C; Haroutunian V
Nucleus basalis lesions impair memory in rats trained on nonspatial and spatial discrimination tasks.
Physiology & behavior 1989;45(5):1025-31.
1989: Haroutunian V; Kanof P D; Davis K L
Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor.
Brain research 1989;487(1):200-3.
1989: Benson D M; Blitzer R D; Haroutunian V; Landau E M
Functional muscarinic supersensitivity in denervated rat hippocampus.
Brain research 1989;478(2):399-402.
1989: Anderson J; Wallace W; Snyder S; Haroutunian V; Roberts J L; Lieberburg I
Cellular forms of the rat and human beta-amyloid precursor protein (BAPP).
Brain research 1989;478(2):391-8.
1989: Santucci A C; Haroutunian V; Tsuboyama G K; Kanof P D; Davis K L
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.
Progress in clinical and biological research 1989;317():1111-20.
1989: Santucci A C; Kanof P D; Haroutunian V
Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.
Psychopharmacology 1989;99(1):70-4.
1988: Shutske G M; Pierrat F A; Cornfeldt M L; Szewczak M R; Huger F P; Bores G M; Haroutunian V; Davis K L
(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
Journal of medicinal chemistry 1988;31(7):1278-9.
1988: Haroutunian V; Knott P; Davis K L
Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function.
Psychopharmacology bulletin 1988;24(3):341-4.
1987: Haroutunian V; Mantin R; Campbell G A; Tsuboyama G K; Davis K L
Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry.
Brain research 1987;403(2):234-42.
1986: Haroutunian V; Kanof P D; Tsuboyama G K; Campbell G A; Davis K L
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):385-93.
1986: Haroutunian V; Kanof P D; Davis K L
Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
Brain research 1986;386(1-2):397-9.
1985: Haroutunian V; Kanof P; Davis K L
Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
Life sciences 1985;37(10):945-52.
1985: Haroutunian V; Barnes E; Davis K L
Cholinergic modulation of memory in rats.
Psychopharmacology 1985;87(3):266-71.
1983: Campbell B A; Haroutunian V
Perceptual sharpening in the developing rat.
Journal of comparative psychology (Washington, D.C. : 1983) 1983;97(1):3-11.
1982: Haroutunian V; Campbell B A
Neural control of the heart-rate-orienting response in preweanling rats.
Behavioral and neural biology 1982;36(1):24-39.
1981: Campbell B A; Haroutunian V
Effects of age on long-term memory: retention of fixed interval responding.
Journal of gerontology 1981;36(3):338-41.
1981: Haroutunian V; Campbell B A
Development and habituation of the heart rate orienting response to auditory and visual stimuli in the rat.
Journal of comparative and physiological psychology 1981;95(1):166-74.
1980: Stehouwer D J; Haroutunian V; Campbell B A
Generalization of habituation to electrical stimulation of the forelimb in neonatal and preweanling rats.
Behavioral and neural biology 1980;29(2):203-15.
1979: Haroutunian V; Campbell B A
Emergence of interoceptive and exteroceptive control of behavior in rats.
Science (New York, N.Y.) 1979;205(4409):927-9.
1979: Haroutunian V; Riccio D C
Age-dependent effects of preconditioning aversive experiences on the retention of conditioned fear in weanling rats.
Behavioral and neural biology 1979;26(2):248-53.
1979: Haroutunian V; Riccio D C
Reduction of ontogenetic retention decrements in rats by pretraining stressful experiences.
Journal of comparative and physiological psychology 1979;93(3):501-11.
1979: Haroutunian V; Riccio D C
Drug-induced "arousal" and the effectiveness of CS exposure in the reinstatement of memory.
Behavioral and neural biology 1979;26(1):115-20.
1977: Haroutunian V; Riccio D C
Effect of arousal conditions during reinstatement treatment upon learned fear in young rats.
Developmental psychobiology 1977;10(1):25-32.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vahram Haroutunian

Research Profile (preview)

Disorders

Anatomy

Living Beings

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vahram Haroutunian (preview)

All Publications